NIH Cuts, Reimbursement Fears Cited as M&A Deals in Life Science Tools, MDx Industries Drop 15 Percent in 2013 | GenomeWeb

NEW YORK (GenomeWeb News) – Though Thermo Fisher Scientific's pending $13.6 billion purchase of Life Technologies sent shockwaves through the industry and led some to speculate about further deals, mergers and acquisitions in the life science tools and molecular diagnostics space were down year over year in 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.